How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Led by Intrepid Growth Partners and GV (Google Ventures), funding advances Iterative Health's position as the leading multispecialty clinical research network CAMBRIDGE, Mass., April 30, ...

UIUC and Stanford's RecursiveMAS lets AI agents collaborate in embedding space instead of text, cutting token usage by 75% ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Chris Gibson built the pioneering AI biotech Recursion Pharmaceuticals on a foundation of bold promises. But after more than a decade at the helm, Gibson stepped down as CEO in November 2025. And his ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

It certainly seems like we’ve entered the era of the Tag Fighter. We’ve got 2XKO repping 2v2 tag action, Marvel Tokon: Fighting Souls planning to introduce the world to a 4v4 fighter later this year, ...

Versus Systems Inc. provides a business-to-business software platform to drive user engagement through gamification and rewards. The company offers the eXtreme Engagement Online platform, which is ...

David Dierking has 20+ years of experience in the investment services industry. He is a contributing writer for a half dozen investment websites. Amanda Jackson has expertise in personal finance, ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Arthur Gies Arthur Gies is an editor for Wirecutter's tech coverage. He's ...